CITTERIO, LUCIA
CITTERIO, LUCIA
Facoltà di Medicina e Chirurgia
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan
2021-01-01 Citterio, L.; Bianchi, G.; Scioli, G. A.; Glorioso, N.; Bigazzi, R.; Cusi, D.; Staessen, J. A.; Cavuto, S.; Ferrandi, M.; Lanzani, C.; Li, X.; Lau, L. -F.; Chiang, C. -E.; Wang, T. -D.; Wang, K. -L.; Ferrari, P.; Manunta, P.
Antihypertensive Treatment Guided By Genetics: Pearl-ht, The Randomized Proof-of-concept Trial Comparing Rostafuroxin With Losartan
2020-01-01 Citterio, L; Bianchi, G; Cusi, D; Ferrandi, M; Lanzani, Cl; Chiang, Ce; Wang, Kl; Ferrari, P; Manunta, P
Association between frailty-related genetic polymorphisms and obesity in older adults: insights from the FRASNET study
2024-01-01 Damanti, S.; Citterio, L.; Zagato, L.; Simonini, M.; De Lorenzo, R.; Ruggiero, M. P.; Santoro, S.; Senini, E.; Farina, F.; Banti, B.; Manunta, P.; Manfredi, A. A.; Lanzani, C.; Rovere-Querini, P.
EARLYMARKERS OF POSTOPERATIVE ACUTE KIDNEY INJURY
2023-01-01 Cocchini, L; De Filippo, M; Lanzani, Cl; Vezzoli, G; Citterio, L; Zagato, L; Raimondo, D; Manunta, P; Simonini, M
GENETIC VARIABILITY IN THE PROSTAGLANDIN E2 PATHWAY IS RELATED TO SALT SENTIVITY IN TREATMENT-NAiVE HYPERTENSIVE PATIENTS
2023-01-01 Gonzalez, Lm; Lanzani, Cl; Simonini, M; Citterio, L; Zagato, L; Tunesi, F; Robles, Rn; Gervasini, G; Manunta, P
IMPACT OF GENETIC FACTORS FOR SALT-SENSITIVE HYPERTENSION AND RENAL DAMAGE ON HOSPITALIZED COVID-19 PATIENTS
2023-01-01 Simonini, M; Citterio, L; Messaggio, E; Zagato, L; Tresoldi, C; De Lorenzo, R; Querini, Pr; Manunta, P; Lanzani, Cl
Klotho shapes kidney complications during chemotherapy in hematological patients
2025-01-01 Simonini, M.; Mastaglio, S.; Citterio, L.; Zagato, L.; El Boustani, M.; Ciceri, F.; Lanzani, C.
LANOSTEROL SYNTHASE RS2254524 POLYMORPHISM MODULATES SALT SENSITIVITY AND RENAL EXPRESSION IN A NOVELMICEMODEL, LSSV643L/V643L
2023-01-01 Citterio, L; Faienza, S; Messaggio, E; Zagato, L; Lanzani, Cl; Simonini, M; Manunta, P
New year, new variant: Drawing lessons from frail elderly people
2022-01-01 Foligno, N.; De Filippo, M.; De Rosa, L.; Bagnati, C.; Pomaranzi, C.; De Lorenzo, R.; Citterio, L.; Messaggio, E.; Zagato, L.; Manfredi, A.; Rovere-Querini, P.; Manunta, P.; Lanzani, C.
PRECISION MEDICINE: LANOSTEROL SYNTHASE AND CYP11B2 GENE POLYMORPHISMS AFFECT BODY NA IN SALT-SENSITIVE HYPERTENSION
2019-01-01 Cuka, E; Lanzani, C; Simonini, M; Zagato, L; Citterio, L; Brioni, E; Hamlyn, Jm; Delli Carpini, S; Manunta, P
Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach
2023-01-01 Cugnata, F.; Scarale, M. G.; De Lorenzo, R.; Simonini, M.; Citterio, L.; Querini, P. R.; Castagna, A.; Di Serio, C.; Lanzani, C. L. S.
PROMISING INNOVATIVE BIOMARKERS FOR FRAILTY AND SARCOPENIA: DATA FROM THE FRASNET STUDY
2023-01-01 Damanti, S; Lanzani, C; Zagato, L; Citterio, L; Manunta, P; Rovere Querini, P
SALT SENSITIVITY AND HYPERTENSIVE NEPHROPATHY: A LINK TO BE DISCOVERED
2023-01-01 Lanzani, Cl; Simonini, M; Citterio, L; Zagato, L; Gonzalez, Lm; Tunesi, F; Contursi, M; Maiucchi, P; Manunta, P
SALT SENSITIVITY AS MARKER FOR HYPERTENSION MANAGEMENT
2023-01-01 Lanzani, Cl; Citterio, L; Simonini, M; Laura, Z; Paolo, M
SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN
2023-01-01 Raimondo, D; Lanzani, Cl; D'Urbano, L; Cocchini, L; De Filippo, M; Vezzoli, G; Citterio, L; Zagato, L; Manunta, P; Simonini, A
Supporting complexity: the psychologist’s role in multidisciplinary management of polycystic kidney disease
2024-01-01 Farinone, S.; Catania, M.; De Rosa, L. I.; Kola, K.; Petrone, M.; Pisoni, M. B.; Gigliotti, A.; Bianca, P.; Maiucchi, P.; Citterio, L.; Carrera, P.; Mancassola, G.; Perego, G.; Milano, F.; Di Mattei, V. E.; Manunta, P.; Vezzoli, G.; Alibrandi, M. T. S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan | 1-gen-2021 | Citterio, L.; Bianchi, G.; Scioli, G. A.; Glorioso, N.; Bigazzi, R.; Cusi, D.; Staessen, J. A.; Cavuto, S.; Ferrandi, M.; Lanzani, C.; Li, X.; Lau, L. -F.; Chiang, C. -E.; Wang, T. -D.; Wang, K. -L.; Ferrari, P.; Manunta, P. | |
| Antihypertensive Treatment Guided By Genetics: Pearl-ht, The Randomized Proof-of-concept Trial Comparing Rostafuroxin With Losartan | 1-gen-2020 | Citterio, L; Bianchi, G; Cusi, D; Ferrandi, M; Lanzani, Cl; Chiang, Ce; Wang, Kl; Ferrari, P; Manunta, P | |
| Association between frailty-related genetic polymorphisms and obesity in older adults: insights from the FRASNET study | 1-gen-2024 | Damanti, S.; Citterio, L.; Zagato, L.; Simonini, M.; De Lorenzo, R.; Ruggiero, M. P.; Santoro, S.; Senini, E.; Farina, F.; Banti, B.; Manunta, P.; Manfredi, A. A.; Lanzani, C.; Rovere-Querini, P. | |
| EARLYMARKERS OF POSTOPERATIVE ACUTE KIDNEY INJURY | 1-gen-2023 | Cocchini, L; De Filippo, M; Lanzani, Cl; Vezzoli, G; Citterio, L; Zagato, L; Raimondo, D; Manunta, P; Simonini, M | |
| GENETIC VARIABILITY IN THE PROSTAGLANDIN E2 PATHWAY IS RELATED TO SALT SENTIVITY IN TREATMENT-NAiVE HYPERTENSIVE PATIENTS | 1-gen-2023 | Gonzalez, Lm; Lanzani, Cl; Simonini, M; Citterio, L; Zagato, L; Tunesi, F; Robles, Rn; Gervasini, G; Manunta, P | |
| IMPACT OF GENETIC FACTORS FOR SALT-SENSITIVE HYPERTENSION AND RENAL DAMAGE ON HOSPITALIZED COVID-19 PATIENTS | 1-gen-2023 | Simonini, M; Citterio, L; Messaggio, E; Zagato, L; Tresoldi, C; De Lorenzo, R; Querini, Pr; Manunta, P; Lanzani, Cl | |
| Klotho shapes kidney complications during chemotherapy in hematological patients | 1-gen-2025 | Simonini, M.; Mastaglio, S.; Citterio, L.; Zagato, L.; El Boustani, M.; Ciceri, F.; Lanzani, C. | |
| LANOSTEROL SYNTHASE RS2254524 POLYMORPHISM MODULATES SALT SENSITIVITY AND RENAL EXPRESSION IN A NOVELMICEMODEL, LSSV643L/V643L | 1-gen-2023 | Citterio, L; Faienza, S; Messaggio, E; Zagato, L; Lanzani, Cl; Simonini, M; Manunta, P | |
| New year, new variant: Drawing lessons from frail elderly people | 1-gen-2022 | Foligno, N.; De Filippo, M.; De Rosa, L.; Bagnati, C.; Pomaranzi, C.; De Lorenzo, R.; Citterio, L.; Messaggio, E.; Zagato, L.; Manfredi, A.; Rovere-Querini, P.; Manunta, P.; Lanzani, C. | |
| PRECISION MEDICINE: LANOSTEROL SYNTHASE AND CYP11B2 GENE POLYMORPHISMS AFFECT BODY NA IN SALT-SENSITIVE HYPERTENSION | 1-gen-2019 | Cuka, E; Lanzani, C; Simonini, M; Zagato, L; Citterio, L; Brioni, E; Hamlyn, Jm; Delli Carpini, S; Manunta, P | |
| Profiling Covid-19 patients with respect to level of severity: an integrated statistical approach | 1-gen-2023 | Cugnata, F.; Scarale, M. G.; De Lorenzo, R.; Simonini, M.; Citterio, L.; Querini, P. R.; Castagna, A.; Di Serio, C.; Lanzani, C. L. S. | |
| PROMISING INNOVATIVE BIOMARKERS FOR FRAILTY AND SARCOPENIA: DATA FROM THE FRASNET STUDY | 1-gen-2023 | Damanti, S; Lanzani, C; Zagato, L; Citterio, L; Manunta, P; Rovere Querini, P | |
| SALT SENSITIVITY AND HYPERTENSIVE NEPHROPATHY: A LINK TO BE DISCOVERED | 1-gen-2023 | Lanzani, Cl; Simonini, M; Citterio, L; Zagato, L; Gonzalez, Lm; Tunesi, F; Contursi, M; Maiucchi, P; Manunta, P | |
| SALT SENSITIVITY AS MARKER FOR HYPERTENSION MANAGEMENT | 1-gen-2023 | Lanzani, Cl; Citterio, L; Simonini, M; Laura, Z; Paolo, M | |
| SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN | 1-gen-2023 | Raimondo, D; Lanzani, Cl; D'Urbano, L; Cocchini, L; De Filippo, M; Vezzoli, G; Citterio, L; Zagato, L; Manunta, P; Simonini, A | |
| Supporting complexity: the psychologist’s role in multidisciplinary management of polycystic kidney disease | 1-gen-2024 | Farinone, S.; Catania, M.; De Rosa, L. I.; Kola, K.; Petrone, M.; Pisoni, M. B.; Gigliotti, A.; Bianca, P.; Maiucchi, P.; Citterio, L.; Carrera, P.; Mancassola, G.; Perego, G.; Milano, F.; Di Mattei, V. E.; Manunta, P.; Vezzoli, G.; Alibrandi, M. T. S. |